ORGENESIS INC.

Profile

Company Names

ORGENESIS INC.

Addresses

20271 GOLDENROD LANE, GERMANTOWN, MD 20876

21 SPARROW CIRCLE, WHITE PLAINS, NY 10605

Phone Numbers

(480) 659-6404
845.591.3144

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2008

State Incorporated:

NEVADA

Total Amount Raised:

$35,204,914.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2024-03-03 
$2,340,903.00 
$2,340,903.00 
$0.00 
Equity 
7
2023-08-31 
$1,000,000.00 
$1,000,000.00 
$0.00 
Equity 
6
2022-03-30 
$14,800,000.00 
$14,800,000.00 
$0.00 
Equity 
5
2020-01-21 
$9,240,000.00 
$9,240,000.00 
$0.00 
Equity 
4
2018-01-26 
$1,200,000.00 
INDEFINITE 
INDEFINITE 
Equity, Debt 
3
2015-12-10 
$5,300,000.00 
$10,000,000.00 
$4,700,000.00 
Equity, Debt 
2
2014-07-07 
$24,011.00 
$24,011.00 
$0.00 
Equity 
1
2013-05-06 
$1,300,000.00 
$1,300,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
YARON 
 
ADLER 
DIRECTOR, EXECUTIVE OFFICER
ORGENESIS INC.   |  TRIPLAY, INC.
DENNIS 
 
BEDORET 
EXECUTIVE OFFICER
ORGENESIS INC.
HUGUES 
 
BULTOT 
DIRECTOR
ORGENESIS INC.
VERED 
 
CAPLAN 
EXECUTIVE OFFICER, DIRECTOR
ORGENESIS INC.   |  CANNABIS THERAPY CORP.
SAV 
 
DIPASQUALE 
EXECUTIVE OFFICER
ORGENESIS INC.
FERBER 
 
FERBER 
EXECUTIVE OFFICER
ORGENESIS INC.
SARAH 
 
FERBER 
EXECUTIVE OFFICER
ORGENESIS INC.
ETTI 
 
HANOCHI 
DIRECTOR
ORGENESIS INC.
DARREN 
 
HEAD 
EXECUTIVE OFFICER
ORGENESIS INC.
ELLIOT 
 
MALTZ 
EXECUTIVE OFFICER
GELESIS INC   |  GELESIS HOLDINGS, INC.   |  ORGENESIS INC.
VICTOR 
 
MILLER 
EXECUTIVE OFFICER
NEOS THERAPEUTICS, INC.   |  BLUECAVA, INC.   |  ORGENESIS INC.   |  MATIC ROBOTS, INC.   |  LUMINARY CLOUD, INC.
ASHISH 
 
NANDA 
DIRECTOR, EXECUTIVE OFFICER
ORGENESIS INC.
MARIO 
 
PHILIPS 
DIRECTOR
ORGENESIS INC.
NEIL 
 
REITHINGER 
EXECUTIVE OFFICER
NEW LEAF BRANDS, INC.   |  ORGENESIS INC.   |  RESTORATION BUILDERS, INC.
DAVID 
 
SIDRANSKY 
DIRECTOR, EXECUTIVE OFFICER
ALFACELL CORP   |  KV PHARMACEUTICAL CO /DE/   |  ROSETTA GENOMICS LTD.   |  MORRIA BIOPHARMACEUTICALS PLC   |  CHAMPIONS ONCOLOGY, INC.   |  CELSUS THERAPEUTICS PLC.   |  Y LABS, INC.   |  IMMUNE PHARMACEUTICALS INC   |  ORGENESIS INC.   |  TAMIR BIOTECHNOLOGY, INC.   |  GALMED PHARMACEUTICALS LTD.   |  ISRAEL BIOTECH FUND II, L.P.   |  ADVAXIS, INC.   |  AYALA PHARMACEUTICALS, INC.
JOSEPH 
 
TENNE 
EXECUTIVE OFFICER
ORGENESIS INC.
DOV 
 
WEINERG 
EXECUTIVE OFFICER
ORGENESIS INC.
GUY 
 
YACHIN 
DIRECTOR
ORGENESIS INC.   |  CANNABIS THERAPY CORP.   |  ORPHEUS BIOSCIENCE, INC.   |  EXXEL PHARMA, INC.
YACHIN 
 
YACHIN 
DIRECTOR
ORGENESIS INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-03-14
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NOT APPLICABLE 
Equity 
2024-03-03 
2023-09-08
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NOT APPLICABLE 
Equity 
2023-08-31 
2022-04-14
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-03-30 
2020-01-29
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-01-21 
2018-02-08
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity, Debt 
2018-01-26 
2015-12-28
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity, Debt 
2015-12-10 
2014-07-09
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2014-07-07 
2013-05-14
D
Link
BIOTECHNOLOGY 
SERVICES-BUSINESS SERVICES, NEC [7389] 
DECLINE TO DISCLOSE 
Equity 
2013-05-06 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
BEAN CAPITAL LIMITED
NONE
MIO CAPITAL LTD.
NONE
NONE
NONE
PHOENIX FINANCIAL INC.
144403